Table 1. Generalities.

Sample	Type(a)	Etiology(b)	Chromosomal aberrations
26	CK, p	U	ND
27	CK, m	U	ND
102,123	CK, p	AD or B	ND
131, 165, 170,	CK, p	A	ND
176, 181, 235,
232
BeWo	CK, cl	B	71–72,XXY,add(X)(p21–22),+1,add(1)(p36),+2,−4,+5,−6,add(7)(p22),−11,−13×2,
			i(13q),−18, der(19)t(9;19)(q13;p13),+mar[cps16]
JEG	CK, cl	B	71–74,XXY,add(X)(p21–22),+2,t(4;11)(p15;q13),+5,add(7)(p22),add(7)(q32),+9,t(10;15)(p10;q10),
			t(10;15)(p10;q10),−11,−13,i(13q),−18,del(18)(q22q),+mar[cps21]
JAR	CK, cl	B	66–68,XXY,add(X)(p22),del(1)(p31),t(1;13)(p13;q14),t(3;3)(q12;qter),add(4)(q22),+5,
			−8,del(8)(q22),−10,add(11)(q10),der(13)(q11q34),add(17)(p12),−19,−21,+mar[cps18]

^(a)CK, p = primary choriocarcinoma; CK, vm = vaginal metastasis from choriocarcinoma; CK, cl = choriocarcinoma cell line.

^(b)A = andromonospermic, AD = , B = , U =  unknown.